Skip to main content
. 2019 Jul 31;10:525. doi: 10.3389/fendo.2019.00525

Figure 1.

Figure 1

Classification of the patients based on peak GH response to ITT < or ≥6 μg/L, the underlying etiology; idiopathic GHD (IGHD), congenital GHD (CGHD), tumoral GHD (TGHD), and the presence of isolated GHD (iGHD) or multiple pituitary hormone defects (MPHD).